Literature DB >> 31050088

Long-term morbidity after a negative sentinel node in breast cancer patients.

Hanne Verbelen1, Wiebren Tjalma2,3,4, Jill Meirte1, Nick Gebruers1,4.   

Abstract

OBJECTIVE: Morbidity after sentinel lymph node biopsy is often underestimated. The aim of this study was to inventory arm and shoulder complaints in sentinel node-negative breast cancer patients post-surgery after long-term follow-up.
METHODS: Sentinel node-negative breast cancer patients with at least 2 years of follow-up after surgery were included in this study. Self-reported arm and shoulder morbidities were assessed using a survey. Patients (n = 126) were asked if they ever developed complaints, if these complaints were still present and whether they were ever treated for these complaints.
RESULTS: After a mean follow-up of 55.5 months (range 25-86 months), the prevalence of the self-reported arm and shoulder complaints was 25.8% for pain, 12.0% for numbness, 6.4% for paraesthesias, 7.1% for lymphedema, 8.0% for axillary web syndrome, 26.2% for loss of strength and 19.5% for limitations in range of motion. About 38.1% of the patients were treated by a physical therapist concerning the experienced complaints after SLNB.
CONCLUSION: Up to 7 years post-surgery a considerable amount of sentinel node-negative patients still suffer from arm and shoulder complaints. These complaints affect the activities of daily living. Therefore, more research is needed regarding the value of early detection and treatment of these complaints.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  breast neoplasms; morbidity; sentinel lymph node biopsy; survey

Mesh:

Year:  2019        PMID: 31050088     DOI: 10.1111/ecc.13077

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.

Authors:  Linda Koehler; Amanda Day; David Hunter; Anne Blaes; Tufia Haddad; Ryan Shanley
Journal:  Arch Phys Med Rehabil       Date:  2022-04-06       Impact factor: 4.060

2.  Prevelance of upper extremity lymphedema and risk factors in patients with mastectomy: Single-center, observational, cross-sectional study.

Authors:  Tuba Tülay Koca; Gökmen Aktaş; Mehmet Emre Kurtgil
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

3.  Redefining Criteria to Ensure Adequate Sentinel Lymph Node Biopsy With Dual Tracer for Breast Cancer.

Authors:  Li Xu; Jiqiao Yang; Zhenggui Du; Faqing Liang; Yanyan Xie; Quanyi Long; Jie Chen; Helin Zeng; Qing Lv
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

4.  Axillary management for early invasive breast cancer patients: Who will truly benefit?

Authors:  Yanbiao Liu; Yan Fan; Zining Jin; Mengyao Cui; Xinmiao Yu; Feng Jin; Xu Wang
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

5.  Acute Cytokine Response During Breast Cancer Surgery: Potential Role of Dexamethasone and Lidocaine and Relationship with Postoperative Pain and Complications - Analysis of Three Pooled Pilot Randomized Controlled Trials.

Authors:  Sandra A S van den Heuvel; Selina E I van der Wal; Ewald M Bronkhorst; Michiel C Warlé; May Ronday; Judith Plat; Nens van Alfen; Leo A B Joosten; Jos G C Lerou; Kris C P Vissers; Monique A H Steegers
Journal:  J Pain Res       Date:  2020-05-27       Impact factor: 3.133

6.  Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control.

Authors:  Claudya Morin; Yamini Patel; Munazza Javid; Sarah E Tevis; Thais Fortes; Peter Flom; Charusheela Andaz; Donna-Marie Manasseh; Patrick Borgen; Kristin E Rojas
Journal:  Ann Surg Oncol       Date:  2021-06-02       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.